Investor

TPG Biotechnology Partners

Last cheque observed Jul 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries DSeries A

Cheques on record
0%of best year0cheques in 12 months, 8 on record
Since the last cheque4486days00hrs00min00sec
Median round$29MRounds led0 of 8Exits1 from the portfolioMostly inUnited States, 100%
Pitch TPG Biotechnology Partners

TPG Biotechnology Partners highlights

  1. 01

    8 rounds on record

  2. 02

    Mostly Series B and Series D: 63% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2014

    1 round

  2. Jul
    VirobaySeries B · US$8.0MWith 4 others
  3. 2011

    2 rounds

  4. Jun
    NovaSomSeries D · US · novasom.com$35MWith 2 others
  5. Jun
    Ultragenyx PharmaceuticalSeries A · US · finsmes.com$45MWith 4 others
  6. 2010

    5 rounds

  7. Aug
    OtonomySeries B · US · otonomy.com$39MWith 3 others
  8. Jun
    Foldrx PharmaceuticalsVenture · US · fiercebiotech.com$29MWith 7 others
  9. Jun
    VeracyteSeries B · US · onbiovc.com$28MWith 3 others
  10. Apr
    GenomaticaSeries C · US · onbiovc.com$15MWith 3 others
  11. Feb
    Quantenna CommunicationsSeries D · US · venturebeat.com$15MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Foldrx PharmaceuticalsBought by PfizerUndisclosedSept 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as TPG Biotechnology Partners. A count of rooms they were both in, not a relationship either has claimed.

Alta PartnersVC firm2rounds togetherDomain AssociatesVC firm2rounds togetherF-Prime CapitalVC firm2rounds togetherFidelity BiosciencesInvestment firm2rounds togetherNovo HoldingsVC firm2rounds together

Quick answers about TPG Biotechnology Partners

What does TPG Biotechnology Partners invest in?

TPG Biotechnology Partners invests most often at Series B and Series D (63% of the rounds on record).

How active is TPG Biotechnology Partners?

8 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2014.

How big are TPG Biotechnology Partners's cheques?

The median round it joins is $29M.

Does TPG Biotechnology Partners lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does TPG Biotechnology Partners invest?

Most of the companies it backs are in the United States (100%).

Is TPG Biotechnology Partners investing now?

No investments in the last 12 months; the latest was in Jul 2014.

Who does TPG Biotechnology Partners invest alongside?

Most often Alta Partners (2 rounds together), Domain Associates (2 rounds together) and F-Prime Capital (2 rounds together).

What kind of investor is TPG Biotechnology Partners?

TPG Biotechnology Partners is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it